Sanofi joins at least eight other drugmakers that have partially or fully loosened their 340B contract pharmacy restrictions in Missouri.

Two More Drugmakers Partially Exempt Missouri Providers from 340B Contract Pharmacy Restrictions

August 29, 2024 William Newton, Associate Editor/Senior Writer Views

Drugmakers Sanofi and Sumitoma Pharma America (SMPA) each announced they are partially exempting Missouri-based providers from their contract pharmacy restrictions [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

Two More Drugmakers Partially Exempt Missouri Providers from 340B Contract Pharmacy Restrictions

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

William Newton

Two More Drugmakers Partially Exempt Missouri Providers from 340B Contract Pharmacy Restrictions

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

William Newton

Site Footer Live